Company Profile
Roam Technologies Pty Ltd is an Australia-based developer of portable oxygen therapy devices, headquartered in Carlton, New South Wales, Australia. Founded in 2014 by Shan Shan Wang, the company operates as an independent privately-held entity employing 8 people and having raised approximately $20K in total funding, serving patients with chronic respiratory diseases in Australia and future target markets.
Core Products and Technologies
Portable Oxygen Concentrators
• JUNO iPOC: Ultra-portable, tankless intelligent oxygen concentrator weighing under 2 kg, delivering 1-3 L/min continuous flow at 90% medical-grade oxygen (+/- 3%)<
• AI Optimization Engine: Real-time adaptive algorithms tailoring oxygen delivery to individual breathing patterns
• Miniaturized PSA Architecture: Patented downsized pressure swing adsorption system with compact adsorbent layers
Platform Technology
• Advanced Chemistry Process: Proprietary oxygen generation methodology for high-purity output
• Real-Time Optimization: Machine learning-driven flow adjustment based on patient activity and respiration
• Continuous Flow Delivery: Tankless system replacing traditional oxygen cylinders and pulse-dose devices
Market Position and Certifications
Roam Technologies holds an emerging position in the global portable oxygen concentrator market, competing with Inogen and Philips Respironics. Key strengths include:
• 11+ years of Australian respiratory device research and development heritage
• AI-Enabled Personalization: Adaptive oxygen delivery algorithms for real-world mobility
• Regulatory pathway: Currently in clinical development; designed for future FDA and TGA submission
• Patent portfolio: Granted patent on POC miniaturization and downsizing architecture with miniaturized PSA design
Corporate Timeline
2014 — Founded in Australia by Shan Shan Wang to develop next-generation portable oxygen therapy
2022 — Completed angel financing and advanced JUNO prototype development
2023 — Selected to present JUNO technology at Cicada Innovations Tech23 deep tech showcase
2024 — Secured grant funding and accelerator support for regulatory preparation
2026 — Named one of four recipients of the NSW Medical Devices Fund round (A$7.4 million shared across four companies) to accelerate clinical trials and commercialization
Target Markets and Applications
• Home Oxygen Therapy: JUNO iPOC for COPD and chronic respiratory patients requiring daily supplemental oxygen
• Mobile Ambulatory Care: Lightweight continuous-flow device enabling patient mobility and independence
• Clinical Development: Pre-market trials and regulatory submissions for US and Australian market entry
Contact Information
Global Headquarters
Address: Carlton, New South Wales, Australia
Website: www.roamtech.ai
Disclaimer
Note: The JUNO device is currently in clinical development and has not yet been approved by the FDA, TGA or any regulatory body.
